Sphingosylphosphorylcholine, D-erythro (CAS 1670-26-4)

D-erythro-Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite that acts as a potent signaling molecule involved in various cellular processes. S1P functions through specific G protein-coupled receptors (S1P receptors), known as S1P1-5, which are widely expressed in various tissues and cell types. Upon binding to its receptors, S1P regulates diverse cellular responses, including cell proliferation, migration, survival, and differentiation. In research, S1P has garnered significant attention for its roles in immunology, neuroscience, and cardiovascular biology. In immunology, S1P is recognized for its ability to modulate lymphocyte trafficking and immune cell activation, thereby influencing immune responses, inflammation, and autoimmunity. Furthermore, S1P signaling has implications in neurobiology, where it regulates neural development, synaptic plasticity, and neuroinflammation, suggesting its potential involvement in neurodegenerative diseases and neurological disorders. Additionally, S1P is implicated in cardiovascular physiology, contributing to vascular development, endothelial barrier function, and vascular tone regulation. Research efforts are underway to explain the precise mechanisms underlying S1P-mediated signaling pathways and its implications in various physiological and pathological conditions, offering insights into potential interventions targeting S1P signaling for the treatment of immune-related disorders, neurological diseases, and cardiovascular ailments.